172 related articles for article (PubMed ID: 6109121)
1. Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure.
Maslowski AH; Ikram H; Nicholls MG; Espiner EA
Lancet; 1981 Jan; 1(8211):71-4. PubMed ID: 6109121
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic, hormonal, and electrolyte responses to withdrawal of long-term captopril treatment for heart failure.
Maslowski AH; Nicholls MG; Ikram H; Espiner EA; Turner JG
Lancet; 1981 Oct; 2(8253):959-61. PubMed ID: 6117729
[TBL] [Abstract][Full Text] [Related]
3. Clinical improvement and hormonal changes in severe cardiac failure after captopril treatment.
McGrath BP; Denham IM; Johnston CI
Aust N Z J Med; 1981 Dec; 11(6):639-44. PubMed ID: 6277291
[No Abstract] [Full Text] [Related]
4. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
[TBL] [Abstract][Full Text] [Related]
5. Acute and chronic effects of captopril therapy in patients with refractory heart failure.
Walsh WF; Lee CL
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):153S-159S. PubMed ID: 6753896
[No Abstract] [Full Text] [Related]
6. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
Wenting GJ; Man in't veld AJ; Woittiez AJ; Boomsma F; Laird-Meeter K; Simoons ML; Hugenholtz PG; Schalekamp MA
Br Heart J; 1983 Jan; 49(1):65-76. PubMed ID: 6336940
[TBL] [Abstract][Full Text] [Related]
7. Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure.
Fitzpatrick D; Nicholls MG; Ikram H; Espiner EA
Br Heart J; 1983 Aug; 50(2):163-9. PubMed ID: 6309203
[TBL] [Abstract][Full Text] [Related]
8. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
Turini GA; Waeber B; Brunner HR
Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
[TBL] [Abstract][Full Text] [Related]
9. Beneficial haemodynamic effect of the angiotensin blocking agent captopril in patients with refractory heart failure.
Lee CL; MacDonald GJ; Walsh WF
Clin Exp Pharmacol Physiol Suppl; 1982; 7():93-7. PubMed ID: 6291831
[No Abstract] [Full Text] [Related]
10. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
Kluger J; Cody RJ; Laragh JH
Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
[TBL] [Abstract][Full Text] [Related]
11. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
Silberbauer K; Punzengruber C; Sinzinger H
Cardiology; 1983; 70(6):297-307. PubMed ID: 6370431
[TBL] [Abstract][Full Text] [Related]
12. Haemodynamic and hormonal effects of captopril in primary pulmonary hypertension.
Ikram H; Maslowski AH; Nicholls MG; Espiner EA; Hull FT
Br Heart J; 1982 Dec; 48(6):541-5. PubMed ID: 6756445
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II is more potent than potassium in regulating aldosterone in cardiac failure: evidence during captopril therapy.
Nicholls MG; Espiner EA; Ikram H; Maslowski AH; Lun S; Scandrett MS
J Clin Endocrinol Metab; 1981 Jun; 52(6):1253-6. PubMed ID: 7014601
[TBL] [Abstract][Full Text] [Related]
14. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
[TBL] [Abstract][Full Text] [Related]
15. Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril.
Atlas SA; Case DB; Yu ZY; Laragh JH
Am J Med; 1984 Aug; 77(2A):13-7. PubMed ID: 6089554
[TBL] [Abstract][Full Text] [Related]
16. A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.
Chatterjee K; Parmley WW; Cohn JN; Levine TB; Awan NA; Mason DT; Faxon DP; Creager M; Gavras HP; Fouad FM
Am Heart J; 1985 Aug; 110(2):439-47. PubMed ID: 3895877
[TBL] [Abstract][Full Text] [Related]
17. [Use of captopril in circulatory failure].
Mareev VIu
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):109-14. PubMed ID: 6753872
[No Abstract] [Full Text] [Related]
18. Hemodynamic and hormonal responses during captopril therapy for heart failure: acute, chronic and withdrawal studies.
Nicholls MG; Ikram H; Espiner EA; Maslowski AH; Scandrett MS; Penman T
Am J Cardiol; 1982 Apr; 49(6):1497-501. PubMed ID: 6803564
[TBL] [Abstract][Full Text] [Related]
19. Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects.
Sharpe DN; Coxon R
Aust N Z J Med; 1982 Oct; 12(5):483-8. PubMed ID: 6758746
[TBL] [Abstract][Full Text] [Related]
20. Clinical and haemodynamic effects of low dose captopril in severe chronic heart failure.
Sharpe DN; Coxon RJ
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):161S-167S. PubMed ID: 6753897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]